MedTrace Logo

A Bioequivalence Study of IMPLANON and Radiopaque IMPLANON (34528)(P05720)

NCT00620464 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2022-02-04

Study results available
· View outcomes & findings →

Summary

The primary purpose of this study is to demonstrate the bioequivalence of IMPLANON and Radiopaque IMPLANON.

Conditions

  • Contraception

Interventions

DRUG

Radiopaque Implanon

Radiopaque rod for 3 years

DRUG

Implanon (etonogestrel implant)

Implanon (etonogestrel implant) for 3 years

Sponsors & Collaborators

  • Organon and Co

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-05-31
Primary Completion
2009-02-28
Completion
2009-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00620464 on ClinicalTrials.gov